Procalcitonin (PCT) is a peptide precursor of the calcitonin hormone. Procalcitonin is a peptide that contains 116 amino acids and has an estimated molecular weight of 14.5 kDa. It can be separated into three parts: immature calcitonin, amino terminus of the PCT region, and calcitonin carboxyl-terminus peptide-1. In 1970, procalcitonin was first classified by Leonard J. Deftos and Bernard Roos. It is produced by endocrine cells of the lung and by C cells of the thyroid. The level of procalcitonin rises in the human body due to injury, shock, or bacterial infection, which increases the production of procalcitonin, resulting in organ dysfunction. The level of procalcitonin in the body can be diagnosed with wet lab analysis using procalcitonin antibody.

The global procalcitonin antibody market is expected to be driven by rise in prevalence of chronic diseases such as sepsis, hepatitis, tuberculosis, and HIV. According to the World Health Organization (WHO), cancer accounted for 8.8 million deaths and HIV related illnesses accounted for around 1.0 million deaths globally in 2015. Procalcitonin antibody is used as a marker to improve identification of bacterial infections and develop antibiotic therapies. This is expected to drive the procalcitonin antibody market. Moreover, increase in funding for research and development by major players and government initiatives for the development of safer, efficient, and innovative products for the treatment of diseases such as cancer boost the growth of the global procalcitonin antibody market. For instance, in 2018, the U.S. Government approved US$ 3 Bn fund for the National Institutes of Health’s research and development activities.

The global procalcitonin antibody market can be segmented based on antibody type, end-user, and region. In terms of antibody type, the global procalcitonin antibody market can be bifurcated into polyclonal procalcitonin antibody and monoclonal procalcitonin antibody. Based on end-user, the global procalcitonin antibody market can be classified into hospitals, research institutes, and others. In terms of region, the global procalcitonin antibody market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region can be divided into specific countries/sub-regions such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC Countries. North America dominated the global procalcitonin antibody market in 2017 because of increase in adoption of new techniques in research and rise in health care spending. According to the U.S. Centers for Medicare & Medicaid Services, national health care spending is projected to increase at an average rate of 5.5% per year from 2017 to 2026 to reach around US$ 5.7 Trn by 2026. Asia Pacific is considered to be the most attractive market for procalcitonin antibody during the forecast period due to surge in health awareness and demand for advanced medical technology.

Key players operating in the global procalcitonin antibody market are bioMérieux SA, HyTest Ltd., F. Hoffmann-La Roche Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Thermo Fisher Scientific, Vazyme Biotech Co., Ltd., Hotgen Biotech Co., Ltd., and Hangzhou Realy Tech Co., Ltd., among others. These players have adopted strategies such as collaborations, agreements, partnerships, and new product launches to gain competitive advantage in the procalcitonin antibody market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Procalcitonin Antibody Market

Pre Book